13F Holdings
中文EN

PIII P3 Health Partners Inc.

Services-Health Services · Nasdaq · SEC CIK 1832511 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.5%
TTM net income YoY60.9%
TTM EPS YoY47.3%
Revenue 3-yr CAGR9.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-5.2%
Net margin-3.3%
FCF margin—
EBITDA margin0.2%

Returns

ROE-115.7%
ROA-7.6%
ROIC (approx.)-33.7%
Asset turnover2.30x

Leverage & solvency

Liabilities / assets70.0%
Debt / equity1.14x
Current ratio0.53x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.26x
Accruals ratio9.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20242025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20202020-12-31
Income statement
Revenue$1.46B$1.50B$1.27B$1.05B$491.06M
SG&A expense$106.31M$112.60M$122.36M$157.28M$53.39M
Operating income-$270.30M-$320.66M-$167.93M-$1.56B-$28.59M
Pretax income-$321.06M-$305.99M-$183.73M-$1.56B-$31.41M
Income tax$2.02M$4.39M$2.69M$1.86M$0
Net income-$147.95M-$135.85M-$57.77M-$270.13M-$31.41M
EBITDA-$186.14M-$234.60M-$81.25M-$1.47B-$27.79M
EPS (basic)-45.26-46.78-0.61-6.50—
EPS (diluted)-45.26-54.06-0.63-6.50—
Weighted avg. shares (diluted)3.27M2.94M294.59M41.58M—
Banking
Net interest income-$55.03M-$22.17M-$15.98M-$11.40M-$2.53M
Provision for credit losses$3.00M$0———
Balance sheet
Cash & equivalents$25.01M$44.10M$40.93M$18.46M$39.90M
Current assets$133.08M$184.14M$166.02M$100.69M$90.88M
PP&E, net$3.37M$5.73M$8.69M$8.84M$6.15M
Goodwill———$0$871,128
Intangibles$492.42M$574.35M$666.73M$751.05M—
Total assets$656.64M$783.42M$860.97M$876.57M$106.44M
Current liabilities$545.26M$496.42M$299.37M$241.66M$90.62M
Short-term debt$45.04M$75.16M$0$0$89,988
Long-term debt$228.37M$108.91M$108.32M$94.42M$45.39M
Total debt$273.41M$184.06M$108.32M$94.42M$45.48M
Total liabilities$796.88M$633.89M$427.31M$353.91M$145.96M
Shareholders' equity-$155.23M$75.94M$142.13M$5.85M$22,714
Net debt$248.40M$139.96M$67.39M$75.96M$5.57M
Cash flow statement
Operating cash flow-$91.24M-$110.13M-$76.03M-$126.02M-$24.60M
Capital expenditure—$0$1.83M$2.23M$2.93M
Free cash flow—-$110.13M-$77.86M-$128.25M-$27.52M
Investing cash flow$129,000$14.53M-$1.83M-$7.73M-$3.17M
Financing cash flow$72.81M$98.77M$100.33M$11.38M$34.76M
Depreciation & amortization$84.16M$86.06M$86.67M$87.29M$795,172
Stock-based compensation$5.58M$5.75M$5.98M$19.40M$447,475

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.